Bone health in cystic fibrosis: use of oral bisphosphonates

Lancet Respir Med. 2013 Jul;1(5):349-50. doi: 10.1016/S2213-2600(13)70096-1. Epub 2013 Jun 2.

Authors

Carole Le Henaff¹, Frederic Velard¹, Jacky Jacquot²

Affiliations

¹ Biomatériaux et inflammation en site osseux, SFR CAP-Santé, University Reims Champagne Ardenne, 51095, Reims, France.
² Biomatériaux et inflammation en site osseux, SFR CAP-Santé, University Reims Champagne Ardenne, 51095, Reims, France. Electronic address: jacky.jacquot@inserm.fr.

PMID: 24429188
DOI: 10.1016/S2213-2600(13)70096-1

No abstract available

Publication types

Comment

MeSH terms

Alendronate / therapeutic use*
Bone Density / drug effects*
Bone Density Conservation Agents / therapeutic use*
Calcifediol / administration & dosage*
Calcium / administration & dosage*
Cystic Fibrosis / complications*
Female
Humans
Male

Substances

Bone Density Conservation Agents
Calcifediol
Calcium
Alendronate